Table 2.
NDG (n = 8) | FDG (n = 8) | RFG (n = 8) | F | P value | |
---|---|---|---|---|---|
Weight (kg)# | 2.90 ± 0.08 | 2.98 ± 0.15 | 2.96 ± 0.07 | 1.160 | 0.333 |
ALT | 44.81 ± 7.95 | 50.86 ± 24.53 | 61.06 ± 20.26 | 1.506 | 0.245 |
AST# | 40.51 ± 6.46 | 84.32 ± 54.94 | 77.91 ± 24.54a | 3.668 | 0.043 |
CREA | 77.38 ± 10.45 | 111.92 ± 11.38a | 127.63 ± 10.84a,b | 44.526 | <0.001 |
TG | 0.62 ± 0.21 | 0.90 ± 0.42 | 0.76 ± 0.28 | 1.567 | 0.232 |
TC# | 2.19 ± 0.30 | 30.32 ± 5.74a | 11.84 ± 2.78a,b | 120.264 | <0.001 |
HDL# | 1.03 ± 0.20 | 3.28 ± 1.61a | 1.58 ± 0.35a | 11.946 | <0.001 |
LDL | 0.91 ± 0.22 | 16.45 ± 3.16a | 6.23 ± 1.53a,b | 120.880 | <0.001 |
Lp-PLA2# | 520.14 ± 51.55 | 1928.88 ± 385.78a | 953.20 ± 96.66a,b | 77.698 | <0.001 |
#The test result of homogeneity of variance was P < 0.05, and Dunnett's T method was used for multiple comparison of P value correction, while the Bonferroni method was used for the other indicators. NDG, normal diet group; FDG, fat diet group; RFG, fat diet with resveratrol; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CREA, creatinine; TG, triglycerides; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Lp-PLA2, lipoprotein-associated phospholipase A2. aStatistically significant when compared to NDG at P < 0.05. bStatistically significant when compared to FDG at P < 0.05.